Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.

Frontiers in immunology - 1 Jan 2021

Martínez-Flores Daniel, Zepeda-Cervantes Jesús, Cruz-Reséndiz Adolfo, Aguirre-Sampieri Sergio, Sampieri Alicia, Vaca Luis

Abstract excerpt

Coronavirus 19 Disease (COVID-19) originating in the province of Wuhan, China in 2019, is caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), whose infection in humans causes mild or severe clinical manifestations that mainly affect the respiratory system. So far, the COVID-19 has caused more than 2 million deaths worldwide. SARS-CoV-2 contains the Spike (S) glycoprotein on its...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Neutralizing
Share to Antibodies, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19 Vaccines

Share to Immune Evasion

Share to Immunodominant Epitopes

Share to Immunogenicity, Vaccine

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 34322129
DOI: 10.3389/fimmu.2021.701501
PMCID: PMC8311925

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants.PMID 34322129Read ↗

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-CoV-2 InfectionSemantic proximity Read ↗

Significance of Conserved Regions in Coronavirus Spike Protein for Developing a Novel Vaccine against SARS-Cov-2 InfectionSemantic proximity Read ↗

Will Mutations in the Spike Protein of SARS-CoV-2 Lead to the Failure of COVID-19 Vaccines?Semantic proximity Read ↗

The SARS-CoV-2 Spike Glycoprotein Biosynthesis, Structure, Function, and Antigenicity: Implications for the Design of Spike-Based Vaccine ImmunogensSemantic proximity Read ↗

What makes SARS‐CoV‐2 unique? Focusing on the spike proteinSemantic proximity Read ↗

The COVID-19 pandemic: viral variants and vaccine efficacySemantic proximity Read ↗

Spike S2 Subunit: The Dark Horse in the Race for Prophylactic and Therapeutic Interventions against SARS-CoV-2Semantic proximity Read ↗

Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity.Semantic proximity Read ↗

The SARS-CoV-2 mutations versus vaccine effectiveness: New opportunities to new challenges.Semantic proximity Read ↗

The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape.Semantic proximity Read ↗

DNA vaccine candidate encoding SARS-CoV-2 spike proteins elicited potent humoral and Th1 cell-mediated immune responses in miceSemantic proximity Read ↗

Spike protein of SARS-CoV-2 variants: a brief review and practical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.